Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Testosterone's effects on COVID-19 are unclear and need more research.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Hormones can improve wound healing by regulating the healing process.

Caffeine may help reduce stress-induced hair loss.

Male infertility and genitourinary birth defects are often linked to genetic issues.

Exosomal miRNAs from stem cells can help improve skin health and delay aging.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Smoking and lighter hair color increase alopecia risk, especially in women and those over 25.

Finasteride may help reduce alcohol cravings and related brain activity.

Oxidative stress affects hair loss in men with androgenetic alopecia.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Understanding proteins linked to PCOS symptoms can improve diagnosis and treatment.